BSE filing, BSE: 542803. Summary written from the filing by ALFA Finder's alert engine.
Vaxfab Enterprises Ltd: key numbers
- Share price
- ₹61.50
- Market cap
- ₹144.6 Cr
- Revenue (annual)
- ₹94.11 Cr
- Net profit (annual)
- ₹3.64 Cr
- P/E (TTM)
- -29.9×Sector 36.4×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 0.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vaxfab Enterprises Ltd
All →Vaxfab Enterprises Management Change
Vaxfab Enterprises appointed Mrs. Dhruvi Patel as Company Secretary and Compliance Officer. This follows the resignation of Mrs. Neha Rishabh Bardia from the same position.
Vaxfab Enterprises Annual General Meeting
Vaxfab Enterprises Ltd held its Annual General Meeting on September 29, 2026. Shareholders approved financial statements, director reappointment, auditor appointment, and authorized capital increase.
Vaxfab Enterprises Other Announcement
The company filed the confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Vaxfab Enterprises Fund Raise of ₹45 Cr
Vaxfab Enterprises approved raising up to ₹45 Crore through a rights issue of equity shares. A Rights Issue Committee was formed to manage the process.
- Value
- ₹45.00 Cr
Vaxfab Enterprises Annual General Meeting
Vaxfab Enterprises Ltd held its 43rd Annual General Meeting on September 29, 2026. The meeting covered routine business, director reappointment, and authorized share capital increase.
Vaxfab Enterprises Board Meeting Date
Vaxfab Enterprises Ltd has scheduled a board meeting for October 01, 2026, to consider a proposal for raising funds through the issuance of securities.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.